CD1d gene is a target for a novel amplicon at 1q22-23.1 in human hepatocellular carcinoma

Molecular Biology Reports

Volumn 37, Issue 1, 2010, Pages 381-387

  Zhang, Shi Guang ^a   Song, Wen Qin ^a   Gao, Ying Tang ^b   Yang, Bin ^b   Du, Zhi ^b  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN THIRD CENTRAL HOSPITAL   (China)

Author keywords

1q22 23.1; CD1d; Copy number variation; Hepatocellular carcinoma

Indexed keywords

CD1D ANTIGEN;

ADULT; AMPLICON; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE NUMBER; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

ANTIGENS, CD1D; CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, PAIR 1; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77749317393     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9817-7     Document Type: Article

References (34)

1. DM Parkin F Bray J Ferlay P Pisani 2001 Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 153 156 10.1002/ijc.1440 10.1002/ijc.1440 1:CAS:528:DC%2BD3MXntVGlu78%3D 11668491 (Pubitemid 32911406)
2. WB Coleman 2003 Mechanisms of human hepatocarcinogenesis Curr Mol Med 3 573 588 10.2174/1566524033479546 10.2174/1566524033479546 1:CAS:528: DC%2BD3sXnslyru7s%3D 14527088 (Pubitemid 37168599)
3. RW Pang JW Joh PJ Johnson M Monden TM Pawlik RT Poon 2008 Biology of hepatocellular carcinoma Ann Surg Oncol 15 962 971 10.1245/s10434-007-9730-z 10.1245/s10434-007-9730-z 18236113
4. R Pang E Tse RT Poon 2006 Molecular pathways in hepatocellular carcinoma Cancer Lett 240 157 169 10.1016/j.canlet.2005.08.031 10.1016/j.canlet.2005.08. 031 1:CAS:528:DC%2BD28XntlGjtb8%3D 16239065 (Pubitemid 44093818)
5. JL Freeman GH Perry L Feuk, et al. 2006 Copy number variation: new insights in genome diversity Genome Res 16 949 961 10.1101/gr.3677206 10.1101/gr.3677206 1:CAS:528:DC%2BD28Xot1Kktb8%3D 16809666 (Pubitemid 44162254)
6. AG Knudson 2001 Two genetic hits (more or less) to cancer Nat Rev Cancer 1 157 162 10.1038/35101031 10.1038/35101031 1:CAS:528:DC%2BD38XlvF2qsLg%3D 11905807
7. C Kumar-Sinha SA Tomlins AM Chinnaiyan 2006 Evidence of recurrent gene fusions in common epithelial tumors Trends Mol Med 12 529 536 10.1016/j.molmed.2006.09.005 10.1016/j.molmed.2006.09.005 1:CAS:528: DC%2BD28XhtFert7fJ 17011825 (Pubitemid 44633807)
8. Y Fujiwara M Monden T Mori Y Nakamura M Emi 1993 Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma Cancer Res 53 857 860 1:CAS:528:DyaK3sXhsVCksbo%3D 8381331
9. N Nishida Y Fukuda T Komeda, et al. 1994 Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma Cancer Res 54 3107 3110 1:CAS:528:DyaK2cXktlahsbw%3D 8205525
10. N Kusano K Shiraishi K Kubo A Oga K Okita K Sasaki 1999 Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features Hepatology 29 1858 1862 10.1002/hep.510290636 10.1002/hep.510290636 1:STN:280: DyaK1M3nvVejsA%3D%3D 10347130 (Pubitemid 29247061)
11. XY Guan Y Fang JS Sham, et al. 2000 Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization Genes Chromosomes Cancer 29 110 116 10.1002/1098-2264(2000)9999:9999<::AID- GCC1022>3.0.CO;2-V 10.1002/1098-2264(2000)9999:9999<::AID-GCC1022>3.0. CO;2-V 1:CAS:528:DC%2BD3cXntVWiur0%3D 10959090
12. P Saelee S Wongkham V Bhudhisawasdi B Sripa S Chariyalertsak S Petmitr 2008 Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma J Cancer Res Clin Oncol 134 1135 1141 10.1007/s00432-008-0379-1 10.1007/s00432-008-0379-1 1:CAS:528:DC%2BD1cXhtVWktb7I 18386060
13. Y Midorikawa S Yamamoto S Ishikawa, et al. 2006 Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays Oncogene 25 5581 5590 10.1038/sj.onc.1209537 10.1038/sj.onc.1209537 1:CAS:528:DC%2BD28XptFCmuro%3D 16785998 (Pubitemid 44344109)
14. H Okamoto K Yasui C Zhao S Arii J Inazawa 2003 PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas Hepatology 38 1242 1249 10.1053/jhep.2003.50457 10.1053/jhep.2003.50457 1:CAS:528:DC%2BD3sXpsVOntrc%3D 14578863 (Pubitemid 37314833)
15. MA Patil I Gütgemann J Zhang, et al. 2005 Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma Carcinogenesis 26 2050 2057 10.1093/carcin/bgi178 10.1093/carcin/bgi178 1:CAS:528:DC%2BD2MXht1ent7fE 16000397 (Pubitemid 41672192)
16. K Yasui S Arii C Zhao, et al. 2002 TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas Hepatology 35 1476 1484 10.1053/jhep.2002.33683 10.1053/jhep.2002.33683 1:CAS:528: DC%2BD38XkvFSnsbc%3D 12029633 (Pubitemid 34966902)
17. C Schlaeger T Longerich C Schiller, et al. 2008 Etiology-dependent molecular mechanisms in human hepatocarcinogenesis Hepatology 47 511 520 10.1002/hep.22033 10.1002/hep.22033 1:CAS:528:DC%2BD1cXitF2luro%3D 18161050 (Pubitemid 351280719)
18. SG Zhang YT Gao WQ Song, et al. 2009 Establishment of a poorly differentiated hepatocellular carcinoma cell line TJ3ZX-01 and research for its cellular origin Chin J Cell Biol 31 101 106
19. W Liu CC Xie Y Zhu, et al. 2008 Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer Neoplasia 10 897 907 10.1593/neo.08428 1:CAS:528:DC%2BD1cXht1Kgs7vJ 18670647
20. K Paulsson JB Cazier F Macdougall, et al. 2008 Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: unexpected similarities with pediatric disease Proc Natl Acad Sci USA 105 6708 6713 10.1073/pnas.0800408105 10.1073/pnas.0800408105 1:CAS:528:DC%2BD1cXmtVyitLo%3D 18458336 (Pubitemid 351754571)
21. LM Butcher OS Davis IW Craig R Plomin 2008 Genome-wide quantitative trait locus association scan of general cognitive ability using pooled DNA and 500K single nucleotide polymorphism microarrays Genes Brain Behav 7 435 446 10.1111/j.1601-183X.2007.00368.x 10.1111/j.1601-183X.2007.00368.x 1:CAS:528:DC%2BD1cXnvVOitrc%3D 18067574 (Pubitemid 351590930)
22. K Wang M Li D Hadley, et al. 2007 PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data Genome Res 17 1665 1674 10.1101/gr.6861907 10.1101/gr.6861907 1:CAS:528:DC%2BD2sXhtlSlu7bE 17921354 (Pubitemid 350074862)
23. T Downey 2006 Analysis of a multifactor microarray study using Partek genomics solution Methods Enzymol 411 256 270 10.1016/S0076-6879(06)11013-7 10.1016/S0076-6879(06)11013-7 1:CAS:528:DC%2BD2sXmtV2ltLw%3D 16939794 (Pubitemid 44291429)
24. Y Inagaki K Yasui M Endo, et al. 2008 CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma Cancer Genet Cytogenet 180 30 36 10.1016/j.cancergencyto.2007.09.013 10.1016/j.cancergencyto.2007.09.013 1:CAS:528:DC%2BD2sXhsVSls73I 18068530 (Pubitemid 350192683)
25. TL Wang C Maierhofer MR Speicher, et al. 2002 Digital karyotyping Proc Natl Acad Sci USA 99 16156 16161 10.1073/pnas.202610899 10.1073/pnas.202610899 1:CAS:528:DC%2BD38Xps1ensLs%3D 12461184 (Pubitemid 35462765)
26. SH Lau XY Guan 2005 Cytogenetic and molecular genetic alterations in hepatocellular carcinoma Acta Pharmacol Sin 26 659 665 10.1111/j.1745-7254.2005. 00126.x 10.1111/j.1745-7254.2005.00126.x 1:CAS:528:DC%2BD2MXlsFCmt7o%3D 15916730 (Pubitemid 40806553)
27. N Wong A Chan SW Lee, et al. 2003 Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression J Hepatol 38 298 306 10.1016/S0168-8278(02)00412-9 10.1016/S0168-8278(02)00412-9 1:CAS:528:DC%2BD3sXhtVemtbs%3D 12586295 (Pubitemid 36286542)
28. NF Ma L Hu JM Fung, et al. 2008 Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma Hepatology 47 503 510 10.1002/hep.22072 10.1002/hep.22072 1:CAS:528:DC%2BD1cXitF2lur0%3D 18023026 (Pubitemid 351280718)
29. AO Speak V Cerundolo FM Platt 2008 CD1d presentation of glycolipids Immunol Cell Biol 86 588 597 10.1038/icb.2008.42 10.1038/icb.2008.42 1:CAS:528:DC%2BD1cXhtF2jsrzM 18542099
30. E Durante-Mangoni R Wang A Shaulov, et al. 2004 Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells J Immunol 173 2159 2166 1:CAS:528:DC%2BD2cXlvVajtLk%3D 15265953
31. K Kakimi LG Guidotti Y Koezuka FV Chisari 2000 Natural killer T cell activation inhibits hepatitis B virus replication in vivo J Exp Med 192 921 930 10.1084/jem.192.7.921 1:CAS:528:DC%2BD3cXntFSltro%3D 11015434 (Pubitemid 30765686)
32. C de Lalla G Galli L Aldrighetti, et al. 2004 Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis J Immunol 173 1417 1425 15240738
33. M Terabe JA Berzofsky 2007 NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis Trends Immunol 28 491 496 10.1016/j.it.2007.05.008 10.1016/j.it.2007.05.008 1:CAS:528:DC%2BD2sXhtlajtrrN 17964217 (Pubitemid 350087811)
34. Y Matsumura AM Moodycliffe DX Nghiem SE Ullrich HN Ananthaswamy 2004 Resistance of CD1d-/- mice to ultraviolet-induced skin cancer is associated with increased apoptosis Am J Pathol 165 879 887 1:CAS:528:DC%2BD2cXnvFKitrY%3D 15331412